COMMUNIQUÉS West-GlobeNewswire

Marrone Bio Announces Closing of Pro Farm Technologies Acquisition
16/09/2019
New Subsidiary Enters into Strategic, Long-Term Exclusive Commercial Agreement in Europe with Corteva Agriscience DAVIS, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII), an [...]
Cassava Sciences Initiates Phase 2b Clinical Study in Alzheimer’s Patients
16/09/2019
First two patients dosed with lead drug candidate, PTI-125 Study initiation follows positive Phase 2a results demonstrating 100% response rate AUSTIN, Texas, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. ( [...]
Bellerophon Receives Orphan Drug Designation for Nitric Oxide in the Treatment of Idiopathic Pulmonary Fibrosis
16/09/2019
WARREN, N.J., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, announced today the U.S. Food and Drug [...]
Resverlogix Provides Update on BETonMACE Phase 3 Trial
16/09/2019
Top-line results projected to be available on or about September 30, 2019 Number of MACE increases from 250 to greater than 275 CALGARY, Alberta, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or [...]
Nova Leap Health Corp. Announces Update on South Central U.S. Acquisition
16/09/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN HALIFAX, Nova Scotia, Sept. 16, 2019 (GLOBE NEWSWIRE) -- NOVA [...]
Auransa to Present New Data on AU-409, a Novel, AI-Generated Drug Candidate for the Treatment of Hepatocellular Carcinoma, at the 13th Annual Conference of the International Liver Cancer Association
16/09/2019
Oral Presentation to Highlight Promising Preclinical Activity of Unique Orally Active Small Molecule PALO ALTO, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Auransa Inc., an artificial intelligence (AI)-driven [...]
Allena Pharmaceuticals Completes Enrollment in Pivotal Phase 3 URIROX-1 Trial Evaluating Reloxaliase in Patients with Enteric Hyperoxaluria
16/09/2019
Topline data from URIROX-1 expected in 4Q 2019 NEWTON, Mass., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and [...]
Fulgent Genetics Launches Picture Genetics, a Consumer-Initiated Genetic Testing Offering
16/09/2019
New line of at-home screening tests combines Fulgent’s advanced NGS solutions with actionable results and genetic counseling options for consumers TEMPLE CITY, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics [...]
BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Following Significant Scientific Achievement
16/09/2019
Company surpasses $3M in accepted investments CHICAGO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D , a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, announced [...]
Extendicare Announces September 2019 Dividend of C$0.04 per Share
16/09/2019
MARKHAM, Ontario, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]
Tabula Rasa HealthCare’s DoseMe® Bayesian Forecasting Method Receives Rating of Most User-Friendly in Clinical Study
16/09/2019
A study from the British Journal of Clinical Pharmacology increases awareness of the applicability of a Bayesian method in healthcare settings MOORESTOWN, N.J., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare [...]
iCAD Exhibiting New Updates and Enhanced Xoft Platform at ASTRO Including Single-Fraction IORT Solution for the Treatment of Early-Stage Breast Cancer
16/09/2019
Enhanced x-ray source technology and full suite of Xoft eBx applicators to be showcased, including those for emerging applications in prostate, brain, and rectal cancers NASHUA, N.H. and CHICAGO, Sept. 16, 2019 (GLOBE [...]
Jason Terris Joins Corizon Health as VP of State Operations
16/09/2019
BRENTWOOD, Tenn., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Jason A. Terris, a 25-year-veteran of corrections and correctional healthcare leadership, has joined Corizon Health as corporate vice president of state operations, [...]
BioCardia Announces Positive DSMB Recommendation to Continue Phase 3 Pivotal CardiAMP Heart Failure Study as Planned
16/09/2019
SAN CARLOS, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the independent [...]
BioRestorative Therapies Scientific Advisory Board Member and Clinical Director of Regenerative Disc/Spine Program, Dr. Wayne J. Olan, to Receive Prestigious Award
16/09/2019
MELVILLE, N.Y., Sept. 16, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that a member of the Company’s [...]
Eloxx Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference on October 3rd, 2019
16/09/2019
WALTHAM, Mass., Sept. 16, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]
Kura Oncology Doses First Patient in Phase 1 Clinical Trial of Menin-MLL Inhibitor KO-539 in Acute Myeloid Leukemia
16/09/2019
– KO-539 is a first-in-class small molecule inhibitor of the menin-MLL interaction – – First-in-human trial to determine MTD, expand to genetic subgroups such as NPM1 – SAN DIEGO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Kura [...]
Wave Life Sciences Announces Fast Track Designation from U.S. FDA for Suvodirsen
16/09/2019
Suvodirsen is an investigational stereopure oligonucleotide in development for the treatment of DMD patients amenable to exon 51 skipping Clinical dystrophin data from interim analysis of ongoing OLE study on track for [...]
Checkpoint Therapeutics Announces Data Presentation at the European Society for Medical Oncology (ESMO) Congress 2019
16/09/2019
NEW YORK, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]

Pages